Skip to Content

Boston Partners All Cap Value Inv BPAVX

Medalist Rating as of | See Boston Partners Investment Hub
  • NAV / 1-Day Return 32.10  /  −0.06 %
  • Total Assets 1.5 Bil
  • Adj. Expense Ratio
    1.050%
  • Expense Ratio 1.050%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.29%
  • Turnover 33%

USD | NAV as of May 21, 2024 | 1-Day Return as of May 21, 2024, 10:13 PM GMT+0

Morningstar’s Analysis BPAVX

Will BPAVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strong execution of a solid approach.

Analyst Andrew Redden

Andrew Redden

Analyst

Summary

Strong execution of a robust, valuation-aware approach makes this an attractive offering.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BPAVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 18.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Johnson & Johnson

2.19 31.7 Mil
Healthcare

JPMorgan Chase & Co

2.00 28.9 Mil
Financial Services

CRH PLC

1.97 28.5 Mil
Basic Materials

AbbVie Inc

1.97 28.5 Mil
Healthcare

Alphabet Inc Class A

1.90 27.4 Mil
Communication Services

Booking Holdings Inc

1.79 25.9 Mil
Consumer Cyclical

Check Point Software Technologies Ltd

1.78 25.7 Mil
Technology

Bristol-Myers Squibb Co

1.74 25.2 Mil
Healthcare

American International Group Inc

1.68 24.3 Mil
Financial Services

Corpay Inc

1.62 23.5 Mil